Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · IEX Real-Time Price · USD
-0.17 (-1.42%)
At close: Apr 12, 2024, 4:00 PM
+0.11 (0.93%)
After-hours: Apr 12, 2024, 7:59 PM EDT

Dynavax Technologies Revenue

In the year 2023, Dynavax Technologies had annual revenue of $232.28M, a decrease of -67.86%. Revenue in the quarter ending December 31, 2023 was $55.60M, a -69.87% decrease year-over-year.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.55B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023232.28M-490.40M-67.86%
Dec 31, 2022722.68M283.24M64.45%
Dec 31, 2021439.44M392.89M844.00%
Dec 31, 202046.55M11.33M32.18%
Dec 31, 201935.22M27.02M329.60%
Dec 31, 20188.20M7.87M2,407.03%
Dec 31, 2017327.00K-10.72M-97.04%
Dec 31, 201611.04M6.99M172.67%
Dec 31, 20154.05M-6.98M-63.29%
Dec 31, 201411.03M-219.00K-1.95%
Dec 31, 201311.25M1.54M15.82%
Dec 31, 20129.71M-11.90M-55.06%
Dec 31, 201121.61M-2.34M-9.75%
Dec 31, 201023.95M-16.37M-40.60%
Dec 31, 200940.32M3.22M8.69%
Dec 31, 200837.09M23.00M163.21%
Dec 31, 200714.09M9.25M190.76%
Dec 31, 20064.85M-9.81M-66.93%
Dec 31, 200514.66M-157.00K-1.06%
Dec 31, 200414.81M13.99M1,693.22%
Dec 31, 2003826.00K-601.00K-42.12%
Dec 31, 20021.43M-932.00K-39.51%
Dec 21, 20012.36M305.00K14.85%
Dec 31, 20002.05M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Addus HomeCare 1.06B
Warby Parker 669.77M
Taro Pharmaceutical Industries 610.83M
U.S. Physical Therapy 604.80M
InMode 492.05M
Veracyte 361.05M
Arcus Biosciences 117.00M
Morphic Holding 521.00K
Revenue Rankings